BTG and MIRADA Collaborate to Develop Dosimetry Software Solutions to Optimise Radioembolisation Therapy in Interventional Oncology

Corporate Breaking News

Home : BTG and MIRADA Collaborate to Develop Dosimetry Software Solutions to Optimise Radioembolisation Therapy in Interventional Oncology

Oct 12 2015	BTG and MIRADA Collaborate to Develop Dosimetry Software Solutions to Optimise Radioembolisation Therapy in Interventional Oncology
LONDON, October 12, 2015 /PRNewswire/ -- BTG plc (LSE: BTG), a global specialist healthcare company and Mirada Medical Ltd, a medical imaging software company, today announced an important collaboration to develop dosimetry software solutions to optimise radioembolisation therapy with...


Source:http://www.prnewswire.com/news-releases/btg-and-mirada-collaborate-to-develop-dosimetry-software-solutions-to-optimise-radioembolisation-therapy-in-interventional-oncology-531962591.html

Related News
» Infosys (NYSE: INFY) Announces Results for the Quarter Ended September 30, 2015 » BTG et MIRADA collaborent pour développer des solutions de logiciels de dosimétrie afin d'optimiser le traitement par radio-embolisation dans l'oncologie interventionnelle